Goldman Sachs
TMDX icon

Goldman Sachs’s Transmedics TMDX Stock Holding History

Goldman Sachs’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$37.2M Sell
559,771
-306,511
-35% -$25.9M ﹤0.01% 2062
2026
Q1 		$86.1M Sell
866,282
-99,649
-10% -$13M 0.01% 1133
2025
Q4 		$118M Buy
965,931
+262,353
+37% +$32.9M 0.01% 894
2025
Q3 		$78.9M Buy
703,578
+386,403
+122% +$45.2M 0.01% 1099
2025
Q2 		$42.5M Sell
317,175
-190,335
-38% -$20.9M 0.01% 1449
2025
Q1 		$34.1M Buy
507,510
+86,721
+21% +$5.96M 0.01% 1527
2024
Q4 		$26.2M Sell
420,789
-119,065
-22% -$11.1M ﹤0.01% 1851
2024
Q3 		$84.8M Buy
539,854
+246,443
+84% +$38M 0.01% 893
2024
Q2 		$44.2M Buy
293,411
+8,338
+3% +$1M 0.01% 1249
2024
Q1 		$21.1M Sell
285,073
-112,210
-28% -$9.25M ﹤0.01% 1796
2023
Q4 		$31.4M Buy
397,283
+38,951
+11% +$2.35M 0.01% 1518
2023
Q3 		$19.6M Buy
358,332
+40,498
+13% +$2.92M ﹤0.01% 1816
2023
Q2 		$26.7M Buy
317,834
+219,615
+224% +$16.8M 0.01% 1599
2023
Q1 		$7.44M Sell
98,219
-23,957
-20% -$1.66M ﹤0.01% 2688
2022
Q4 		$7.54M Sell
122,176
-50,732
-29% -$2.7M ﹤0.01% 2825
2022
Q3 		$7.22M Buy
172,908
+134,442
+350% +$5.85M ﹤0.01% 2813
2022
Q2 		$1.21M Buy
38,466
+12,287
+47% +$328K ﹤0.01% 4463
2022
Q1 		$705K Buy
26,179
+10,740
+70% +$192K ﹤0.01% 5099
2021
Q4 		$296K Sell
15,439
-5,278
-25% -$132K ﹤0.01% 5679
2021
Q3 		$686K Sell
20,717
-4,650
-18% -$142K ﹤0.01% 5004
2021
Q2 		$842K Sell
25,367
-9,502
-27% -$263K ﹤0.01% 4887
2021
Q1 		$1.45M Buy
34,869
+22,792
+189% +$701K ﹤0.01% 4309
2020
Q4 		$240K Sell
12,077
-722
-6% -$10.7K ﹤0.01% 4999
2020
Q3 		$176K Sell
12,799
-4,080
-24% -$69.9K ﹤0.01% 4965
2020
Q2 		$302K Buy
16,879
+2,155
+15% +$33.7K ﹤0.01% 4626
2020
Q1 		$178K Buy
+14,724
New +$247K ﹤0.01% 4747

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Goldman Sachs's TMDX Position: Q2 2026 in Review

Goldman Sachs reduced its Transmedics (TMDX) stake by 35% in Q2 2026, selling an estimated $25.9M and leaving 559,771 shares worth $37.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2062.

Goldman Sachs first reported a position in TMDX in Q1 2020 and has held it in 26 quarters since. The position peaked at $118M in Q4 2025. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Goldman Sachs held 559,771 shares of Transmedics worth $37.2M as of Q2 2026.
  • Goldman Sachs sold 306,511 Transmedics shares in Q2 2026, an estimated $25.9M.
  • Transmedics made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #2062 holding.
  • Goldman Sachs first reported a position in Transmedics in Q1 2020 and has held it in 26 quarters since.
  • Goldman Sachs's Transmedics position peaked at $118M in Q4 2025.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.